Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:158 |
|---|---|
| Enthalten in: |
Pharmacological research - 158(2020) vom: 01. Aug., Seite 104507 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Marino, Francesca [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anti-Inflammatory Agents |
|---|
| Anmerkungen: |
Date Completed 04.06.2021 Date Revised 04.06.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.phrs.2019.104507 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM302830111 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM302830111 | ||
| 003 | DE-627 | ||
| 005 | 20231225111543.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.phrs.2019.104507 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1009.xml |
| 035 | |a (DE-627)NLM302830111 | ||
| 035 | |a (NLM)31678639 | ||
| 035 | |a (PII)S1043-6618(19)31072-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Marino, Francesca |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cancer risk and tumour necrosis factor inhibitors in patients with inflammatory arthritis |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.06.2021 | ||
| 500 | |a Date Revised 04.06.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Biological agents | |
| 650 | 4 | |a Cancer | |
| 650 | 4 | |a Rheumatoid arthritis | |
| 650 | 4 | |a Spondyloarthritis | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor Inhibitors |2 NLM | |
| 650 | 7 | |a Tumor Necrosis Factor-alpha |2 NLM | |
| 700 | 1 | |a Nucera, Valeria |e verfasserin |4 aut | |
| 700 | 1 | |a Gerratana, Elisabetta |e verfasserin |4 aut | |
| 700 | 1 | |a Fiorenza, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Sangari, Donatella |e verfasserin |4 aut | |
| 700 | 1 | |a Miceli, Gianfranco |e verfasserin |4 aut | |
| 700 | 1 | |a Masala, Ignazio Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Atzeni, Fabiola |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmacological research |d 1992 |g 158(2020) vom: 01. Aug., Seite 104507 |w (DE-627)NLM012597384 |x 1096-1186 |7 nnns |
| 773 | 1 | 8 | |g volume:158 |g year:2020 |g day:01 |g month:08 |g pages:104507 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.phrs.2019.104507 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 158 |j 2020 |b 01 |c 08 |h 104507 | ||